.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Julphar
Covington
Argus Health
Merck
McKinsey
Colorcon
Healthtrust
Express Scripts
Harvard Business School

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050582

« Back to Dashboard

NDA 050582 describes DORYX, which is a drug marketed by Mayne Pharma Intl, Warner Chilcott, and Mayne Pharma, and is included in three NDAs. It is available from two suppliers. There are five patents protecting this drug and seven Paragraph IV challenges. Additional details are available on the DORYX profile page.

The generic ingredient in DORYX is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for 050582

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Dental and Oral Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Jul 22, 1985TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED RELEASE;ORALStrengthEQ 75MG BASE
Approval Date:Aug 13, 2001TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Citi
QuintilesIMS
Merck
Julphar
Accenture
Cantor Fitzgerald
US Department of Justice
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot